PP
KANG

Paloma Partners’s iKang Healthcare Group, Inc. KANG Stock Holding History

Paloma Partners’s Portfolio KANG Stock Details KANG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-38,152
Closed -$781K – 2134
2018
Q2 		$781K Sell
38,152
-33,683
-47% -$679K 0.01% 823
2018
Q1 		$1.43M Buy
+71,835
New +$1.21M 0.02% 779

Other funds holding KANG

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CI
Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return

Paloma Partners's KANG Position: Q3 2018 in Review

Paloma Partners sold out of iKang Healthcare Group, Inc. (KANG) in Q3 2018, closing a stake of 38,152 shares — an estimated $781K sold.

Paloma Partners first reported a position in KANG in Q1 2018 and held it in 2 quarters. The position peaked at $1.43M in Q1 2018. 52 funds tracked by Wall St. Rank hold KANG as of Q3 2018.

  • Paloma Partners reported no remaining iKang Healthcare Group, Inc. position as of Q3 2018 after selling out during the quarter.
  • Paloma Partners sold 38,152 iKang Healthcare Group, Inc. shares in Q3 2018, an estimated $781K.
  • Paloma Partners first reported a position in iKang Healthcare Group, Inc. in Q1 2018 and held it in 2 quarters.
  • Paloma Partners's iKang Healthcare Group, Inc. position peaked at $1.43M in Q1 2018.
  • 52 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q3 2018.

Based on Paloma Partners's 13F filing for Q3 2018, filed 14 Nov 2018.